Membrane composition and lipid to protein ratio modulate amyloid kinetics of yeast prion protein

Literature Information

Publication Date 2021-02-05
DOI 10.1039/D0CB00203H
Impact Factor 0
Authors

Arnab Bandyopadhyay, Achinta Sannigrahi, Krishnananda Chattopadhyay


View Original

Abstract

Understanding of prion aggregation in a membrane environment may help to ameliorate neurodegenerative complications caused by the amyloid forms of prions. Here, we investigated the membrane binding-induced aggregation of yeast prion protein Sup35. Using the combination of fluorescence correlation spectroscopy (FCS) at single molecule resolution and other biophysical studies, we establish that lipid composition and lipid/protein ratio are key modulators of the aggregation kinetics of Sup35. In the presence of a zwitterionic membrane (DMPC), Sup35 exhibited novel biphasic aggregation kinetics at lipid/protein ratios ranging between 20 : 1 and 70 : 1 (termed here as the optimum lipid concentration, OLC). In ratios below (low lipid concentration, LLC) and above (ELC, excess lipid concentration) that range, the aggregation was found to be monophasic. In contrast, in the presence of negatively charged membranes, we did not observe any bi-phasic aggregation kinetics in the entire range of protein to lipid ratios. Our results provide a mechanistic description of the role that membrane concentration/composition-modulated aggregation may play in neurodegenerative diseases.

Related Literature

Tuning the dissolution kinetics of wollastonite via chelating agents for CO2 sequestration with integrated synthesis of precipitated calcium carbonates

Huangjing Zhao, Youngjune Park, Dong Hyun Lee, Ah-Hyung Alissa Park

2013-07-04 Paper

DOI: 10.1039/C3CP52459K

Resonance optical manipulation of nano-objects based on nonlinear optical response

Tetsuhiro Kudo, Hajime Ishihara

2013-07-08 Perspective

DOI: 10.1039/C3CP51969D

Surface plasmon resonance-based fiber optic hydrogen sulphide gas sensor utilizing Cu–ZnO thin films

Rana Tabassum, Satyendra K. Mishra, Banshi D. Gupta

2013-05-30 Paper

DOI: 10.1039/C3CP51525G

Contents list

Front/Back Matter

DOI: 10.1039/C3CP90114A

Front cover

Cover

DOI: 10.1039/C3CP90084C

Shape-dependent two-photon absorption in two-dimensionally extended benzoporphyrin arrays

Pyosang Kim, Sujin Ham, Juwon Oh, Hiroki Uoyama, Hajime Watanabe, Kazunari Tagawa, Hidemitsu Uno, Dongho Kim

2013-04-04 Communication

DOI: 10.1039/C3CP50166C

Highly sensitive, selective and reusable mercury(ii) ion sensor based on a ssDNA-functionalized photonic crystal film

Yuqi Zhang, Loujun Gao, Liping Wen, Liping Heng, Yanlin Song

2013-05-10 Paper

DOI: 10.1039/C3CP51324F

Conformational preferences of furan- and thiophene-based arylamides: a combined computational and experimental study

Jhenny F. Galan, Chi Ngong Tang, Shubhashis Chakrabarty, Zhiwei Liu, Vojislava Pophristic

2013-05-08 Paper

DOI: 10.1039/C3CP50353D

You might also like

Compound Q&A

How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?

Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...

898825-89-3N-Methoxy-N-methyl-1...
Compound Q&A

How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?

N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...

1318338-47-4N-(4-Biphenylyl)dibe...
Compound Q&A

What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?

The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...

1713-07-13-Acetamido-5-amino-...
Compound Q&A

How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?

Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...

61820-03-9Benzyl 2-O-acetyl-3,...
Compound Q&A

What regulatory guidelines apply to 2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3)?

2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3) is regulated under the Glob...

438050-52-32-Ethylpiperazine di...
Compound Q&A

What regulatory guidelines apply to 1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 119462-56-5)?

1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 11946...

119462-56-51,1'-[1,3-Phenyleneb...
Compound Q&A

Are there alternatives to 5-Fluoro-2-(1-pyrrolidinyl)pyridine (CAS: 1287217-79-1) in synthesis?

Several alternatives can be used in the synthesis of 5-Fluoro-2-(1-pyrrolidinyl)...

1287217-79-15-Fluoro-2-(1-pyrrol...
Compound Q&A

What precautions should be taken when handling 6-Bromoimidazo[1,2-a]pyridin-8-amine (CAS: 676371-00-9)?

When handling 6-Bromoimidazo[1,2-a]pyridin-8-amine, it is important to wear appr...

676371-00-96-Bromoimidazo[1,2-a...
Compound Q&A

Are there alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochloride (CAS: 1049740-22-8) in synthesis?

Alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochlo...

1049740-22-8(2S,4R)-4-(4-Nitrobe...
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.